Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 3761-3770 of 11639

Edit search filters
  1. Pediatric MSC-AFP Sub-study For Crohn's Fistula

    Rochester, MN

  2. A Study Of SC-007 In Subjects With Advanced Cancer

    Rochester, MN

  3. Autologous Culture Expanded Adipose Derived MSCs For Treatment Of Painful Hip OA

    Rochester, MN

  4. Efficacy and Safety Trial of MK-8931 in Participants With Prodromal Alzheimer's Disease (MK-8931-019)

  5. Absorbable versus Non-Absorbable Suture in Patients Undergoing Carpal Tunnel and Trigger Finger Wound Closure

    Rochester, MN

  6. Ultrasound Utility in Carpal Tunnel Syndrome

    Scottsdale/Phoenix, AZ

  7. Stem Cell Therapy for Chronic Kidney Disease

    Jacksonville, FL

  8. Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease

    Jacksonville, FL

  9. A Study of Idelalisib Combined with BI 836826 for Patients with Chronic Lymphocytic Leukemia

    Rochester, MN

  10. Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma

    Rochester, MN

.

Mayo Clinic Footer